Davis Polk advised the underwriters on the deal. Sidley Austin advised Ocumension Therapeutics on the deal. Ocumension Therapeutics completed its initial public offering on the Hong…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now